DYNLRB1 and neoplasm: Particularly in the D-bLP + laser/M-bLP group, tumors were obviously shrunk at first 9 days and completely abated except 3 of 6 mice, leading to a remarkable inhibition on tumor growth and effective prevention of tumor relapse (Fig. 9b; Supplementary Fig. 31 and Supplementary Table 2).